- Home
- CLRB vs LEDS Comparison
CLRB vs LEDS Comparison
Compare CLRB & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- LEDS
- Stock Information
- Founded
- CLRB 2002
- LEDS 2005
- Country
- CLRB United States
- LEDS Taiwan
- Employees
- CLRB N/A
- LEDS N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- LEDS Semiconductors
- Sector
- CLRB Health Care
- LEDS Technology
- Exchange
- CLRB Nasdaq
- LEDS Nasdaq
- Market Cap
- CLRB 12.8M
- LEDS 11.8M
- IPO Year
- CLRB N/A
- LEDS 2010
- Fundamental
- Price
- CLRB $0.32
- LEDS $1.80
- Analyst Decision
- CLRB Buy
- LEDS
- Analyst Count
- CLRB 2
- LEDS 0
- Target Price
- CLRB $28.00
- LEDS N/A
- AVG Volume (30 Days)
- CLRB 1.3M
- LEDS 20.6K
- Earning Date
- CLRB 03-13-2025
- LEDS 04-02-2025
- Dividend Yield
- CLRB N/A
- LEDS N/A
- EPS Growth
- CLRB N/A
- LEDS N/A
- EPS
- CLRB N/A
- LEDS N/A
- Revenue
- CLRB N/A
- LEDS $4,794,000.00
- Revenue This Year
- CLRB N/A
- LEDS N/A
- Revenue Next Year
- CLRB $208.14
- LEDS N/A
- P/E Ratio
- CLRB N/A
- LEDS N/A
- Revenue Growth
- CLRB N/A
- LEDS N/A
- 52 Week Low
- CLRB $0.22
- LEDS $0.92
- 52 Week High
- CLRB $4.17
- LEDS $2.48
- Technical
- Relative Strength Index (RSI)
- CLRB 51.53
- LEDS 60.44
- Support Level
- CLRB $0.30
- LEDS $1.59
- Resistance Level
- CLRB $0.34
- LEDS $1.89
- Average True Range (ATR)
- CLRB 0.03
- LEDS 0.16
- MACD
- CLRB 0.01
- LEDS 0.00
- Stochastic Oscillator
- CLRB 65.14
- LEDS 76.32
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.